SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amidst community discussions around political topics, ranging from the Supreme Court to the media landscape.  Conversations also touch on potential catalysts related to autism research and potential actions from the Trump administration.  The stock's movement appears closely tied to broader socio-political sentiment and commentary.

MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.

MicroCloud Hologram Inc

MicroCloud Hologram Inc is trending due to a press release connecting it to AI and quantum computing, sparking speculative trading. Community members are highly bullish, drawing parallels to past rallies and anticipating significant upside, while acknowledging the potential for volatility. Traders are closely monitoring volume and technical indicators as they weigh the potential for a multi-day breakout.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending amid speculation about a hyperscaler deal and its ties to Nvidia's AI initiatives, fueled by strong price action. The community is buzzing about potential partnerships and the anticipation of significant upside, with some traders pointing to potential short squeeze scenarios. APLD is viewed by some as strategically positioned to capitalize on AI infrastructure demand.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending as investors discuss its close relationship with NVIDIA and OpenAI, particularly following NVIDIA's recent investment in OpenAI. Community members are debating the sustainability of the company's business model, especially regarding its reliance on NVIDIA and the AI infrastructure buildout. Bearish sentiment revolves around insider selling and the belief that the stock is overvalued, while bulls anticipate further upside and significant growth potential.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors discuss the potential impact of the new F3 factory and strong ES8 demand, while also weighing concerns about production capacity and delivery timelines. Community members are actively debating insurance registration numbers and Q3 delivery targets, with some expressing concerns about international sales and overall production efficiency. Bullish sentiment is fueled by price target upgrades from analysts, although some caution is present regarding profitability and macro-economic factors.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

Better Home & Finance is trending due to increased attention from investors, sparked by optimistic commentary around the company's AI capabilities and potential for significant gains, drawing comparisons to Shopify in the mortgage industry. Community discussions revolve around the validity of the hype and potential for a short squeeze given the stock's low float. Some are skeptical of management and the company's history, while others are excited about the potential for significant returns.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI ($SOUN) is trending as the stock breaks above $17, reaching an 8-month high amid bullish call option activity. Community members are optimistic about further upside this week, with some anticipating a run to $20 and higher, fueled by bullish flow and potential AI sector breakouts. Many are pointing to consistent new contracts, a strong chart, and institutional buying as reasons for their continued bullishness.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending amidst discussions about a potential link between Tylenol use during pregnancy and autism, fueled by statements from the Trump administration, despite the company's denial and existing research suggesting otherwise. Community sentiment is divided, with some expressing concerns over potential lawsuits and a possible decline in Tylenol sales, while others dismiss the claims, viewing the dip as a buying opportunity and criticizing the administration's stance. The stock's movement reflects this uncertainty, influenced by both the immediate news and the broader context of the company's recent spin-off from Johnson & Johnson ($JNJ) and existing litigation surrounding related products.

The Southern Co is a holding company, which engages in the generation and sale of electricity. It operates through the following segments: Traditional Electric Operating Companies, Southern Power, and Southern Company Gas. The Traditional Electric Operating Companies segment refers to vertically integrated utilities that own generation, transmission and distribution facilities, and supplies electric services in the states of Alabama, Georgia, Florida, and Mississippi. The Southern Power segment constructs, acquires, owns, and manages generation assets such as renewable energy projects and sells electricity in the wholesale market. The Southern Company Gas segment distributes natural gas through natural gas distribution facilities in the states of Illinois, Georgia, Virginia, New Jersey, Florida, Tennessee, and Maryland. The company was founded on November 9, 1945, and is headquartered in Atlanta, GA.

Southern Company

SO is trending amid discussions about its capital expenditure plan for energy transition and solar power purchase agreements, as well as recent analyst ratings. The community is weighing the company's dividend safety, regulatory landscape, and potential growth opportunities in the utility sector. Community members are actively discussing potential ROI and options trading strategies.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending as investors react to news of potential partnerships and expansions within the AI server market, specifically highlighting Supermicro's role in AI infrastructure. Community discussions revolve around the impact of Nvidia's involvement with OpenAI and Intel, with some speculating on future deals, while others express concern over management and stock manipulation amid anticipation for upcoming earnings. Despite some negative sentiment, many remain bullish on SMCI's long-term prospects in the growing AI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board.&nbsp;That decision comes via a partnership with Titan Partners Group and GSR, which together committed more than one hundred million dollars to seed the new Litecoin treasury. MEI Pharma frames the move as diversification, but insiders admit the Litecoin narrative also attracts retail eyeballs that usually ignore cancer drug pipelines.&nbsp;Litecoin has processed cheap, reliable payments for fourteen years, a résumé that gives MEI Pharma confidence the treasury will stay liquid when clinical trials burn cash. BitPay data shows Litecoin beating many bigger‑name coins in actual commerce, and that transaction velocity reassures auditors that the treasury is more than a speculative bet.&nbsp;Charlie Lee’s board seat is no vanity hire. He carries credibility with miners, exchanges, and payment gateways, and his presence signals that the Litecoin treasury will receive continuous technical guidance. For MEI Pharma, that guidance could translate into direct vendor payments in Litecoin, cross‑border payroll experiments, or even patient reimbursement pilots once regulators clear the path.&nbsp;The Litecoin treasury also opens strategic hedging: if drug approvals lag, a rising Litecoin price buffers the balance sheet; if the token sinks, at least R&amp;D still owns the spotlight. Critics scoff that a biotech firm should not moonlight as a crypto fund, yet MEI Pharma argues a Litecoin treasury is no riskier than holding foreign bonds in volatile rate cycles.&nbsp;The mechanics are straightforward. Litecoin lands in cold storage under a multi‑sig, treasury policy caps allocation at a prudent percentage of liquid assets, and quarterly reports will show fair‑value marks. Should Litecoin spike, MEI Pharma can liquidate slices to extend runway without diluting shareholders.&nbsp;Should it crash, the treasury remains a minority holding, and Lee’s technical oversight helps avoid security mishaps. Either scenario generates case‑study fodder for CFOs curious about crypto diversification.&nbsp;Litecoin gains institutional clout, MEI Pharma gains branding heat, and the treasury playbook inches toward mainstream adoption. In the end, Litecoin gets a new billboard, MEI Pharma gets optionality, and the treasury debate takes a very public turn.Also See: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/icp-apps-by-conversation-caffeine-says-yes/ch8M1bpR5sC">Apps by Conversation? Caffeine Says Yes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a Litecoin logo seen displayed on a smartphone screen in Athens, Greece on September 22, 2023. (Photo illustration by Nikolas Kokovlis/NurPhoto via Getty Images)

MEI Pharma Trades Cash For LTC

Biotech firm MEI Pharma shifts cash into Litecoin, adds Charlie Lee to its board, and pioneers a corporate crypto treasury.

MEI Pharma Bets $100M on Litecoin Treasury

Cryptocurrency

MEI Pharma moves a nine‑figure treasury slice into Litecoin and seats the coin’s creator on its board.

MEI Pharma, Inc. (MEIP) announced on Friday a $100 million private placement to initiate a Litecoin treasury strategy, sending the company's shares trading 37% higher at the time of writing.The company announced that it has entered into securities purchase agreements for a private investment in public equity (PIPE) transaction, involving the purchase and sale of over 29 million shares of common stock for $3.42 per share.The pharmaceutical company stated that it anticipates aggregate gross proceeds of approximately $100 million, net of expenses and fees. <a href="https://stocktwits.com/symbol/MEIP">MEI Pharma</a> intends to use the funds to acquire the native cryptocurrency of the Litecoin blockchain, commonly referred to as “LTC”, which will serve as the company’s primary treasury reserve asset.On Stocktwits, retail sentiment around MEI Pharma trended in the ‘extremely bullish’ territory, coupled with ‘extremely high’ message volume.<figure class="image"><img style="aspect-ratio:625/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_18_at_12_00_07_PM_png_6d3faa970c.webp" alt="MEIP's Sentiment Meter and Message Volume as of 12 p.m. ET on July 18, 2025 | Source: Stocktwits" width="625" height="58"><figcaption>MEIP's Sentiment Meter and Message Volume as of 12 p.m. ET on July 18, 2025 | Source: Stocktwits</figcaption></figure>The transaction will also make MEI the first and only publicly traded LTC holder on a national exchange, it added. Litecoin (LTC) is a leading peer-to-peer cryptocurrency created by Charlie Lee in October 2011.MEI will appoint Charlie Lee, also a lead investor in the placement, to its Board of Directors, upon the closing of the transaction, and GSR, a preeminent digital asset market maker, as its digital asset and treasury management advisor to oversee the implementation of its Litecoin Treasury Strategy.A Stocktwits user applauded Charlie Lee's involvement in the company, opining that it is “huge.”<stembedurl>https://stocktwits.com/cjstocksup/message/621527406</stembedurl>The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20250718252887/en/MEI-Pharma-Announces-%24100000000-Private-Placement-to-Initiate-Litecoin-Treasury-Strategy-Becoming-First-and-Only-Publicly-Traded-LTC-Holder-on-a-National-Exchange">stated</a> that the transaction marks a significant milestone in its long-term strategic plan. By integrating Litecoin into its treasury operations, MEI gains access to a decentralized monetary asset that complements its cash management framework.The closing of the PIPE is expected to occur on or about July 22, 2025, subject to the satisfaction of customary closing conditions.A more pessimistic user on Stocktwits, however, highlighted the company’s financials, opining that its future viability hinges on funding or partnerships.<stembedurl>https://stocktwits.com/Rome777/message/621525808</stembedurl>MEIP stock is up by 150% this year and by about 115% over the past 12 monthsRead Next: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-draws-wall-street-ire-after-third-patient-death-this-year/ch8kMF7R5qY">Sarepta Draws Wall Street Ire After Third Patient Death This Year: Analyst Says ‘Deeply Concerning’ The Incident Wasn’t Reported Earlier</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

MEI Pharma Announces $100M Placement To Initiate Litecoin Treasury Strategy: Retail Cheers Charlie Lee’s Addition To Company Board

MEI Pharma intends to use the funds to acquire the native cryptocurrency of the Litecoin blockchain, commonly referred to as “LTC”, which will serve as the company’s primary treasury reserve asset.

Equity

MEI Pharma intends to use the funds to acquire the native cryptocurrency of the Litecoin blockchain, commonly referred to as “LTC”, which will serve as the company’s primary treasury reserve asset.


MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today reported results for its quarter ended December 31, 2024. As previously announced in July 2024, the Company is continuing its review and evaluation...

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today reported results for its quarter ended September 30, 2024. As previously announced in July 2024, the Company is continuing its review and...

MEI Pharma Reports Fiscal Year End 2024 Cash Position

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today reported results for its fiscal year ended June 30, 2024. Previously on July 22, 2024, the Company announced the commencement of an evaluation of...

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today announced that it has engaged Oppenheimer & Co. Inc. to serve as the Companys exclusive financial advisor to assist in its previously announced...

MEI Pharma to Consider Strategic Alternatives

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today announced that its Board of Directors has determined unanimously to begin evaluation of the Companys strategic alternatives, including potential...

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

Glancy Prongay & Murray LLP (GPM) announces its investigation of MEI Pharma, Inc. (Nasdaq: MEIP) concerning the Company and its directors and officers possible violations of state laws. If you own...

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today reported...

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.

Lite Strategy Inc.

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

Current Price	$2.58
Prev Close	$2.80
Open	$2.80
Dividend Yield	0.00%
50-Day Moving Average	$4.56
Beta	0.61
Avg. Volume	487,385.76
PE Ratio	-0.59

52-Week High	$9.00
52-Week Low	$1.46
Market Capitalization	$91.95M
EPS (Annual)	$2.67
Price to Book	0.95
Revenue Per Employee	$2.33M
Enterprise Value/EBITDA	N/A

MEIP
MEI Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MEIP News

MEIP MEI Pharma Inc